SUNNYVALE, CA -- (Marketwire) -- 03/01/11 -- Arteris Inc., the leading supplier of network-on-chip (NoC) interconnect IP solutions and CEVA, Inc., ((NASDAQ: CEVA); (LSE: CVA)), the leading licensor of silicon intellectual property (SIP) platform solutions and DSP cores, today announced that Arteris has joined the CEVAnet partner program, bringing multi-core interconnect expertise to the comprehensive third-party technology offerings for CEVA DSP cores. In addition, CEVA has licensed Arteris' advanced FlexNoC interconnect IP for optimizing CEVA's future multi-core platforms.
For ... read more
Astera Software, a leading provider of data integration solutions through its Centerprise Data Integration platform, announces the release of its Centerprise Connector for COBOL, one of the oldest and most widely used programming languages by enterprises and government organizations.
Centerprise Connector for COBOL provides the ability to integrate data housed in legacy systems into newer applications that allow for greater access to and more flexible use of information for business decision makers. By eliminating the need for hard to ... read more
CellTrust Corporation, the recognized leader in mobile secure messaging and secure applications for mobile phones (www.celltrust.com), today announced that CellTrust's mobile banking products based on SecureSMS Secure Mobile information management (SMIM) architecture are not affected by the new Zeus Trojan, exposed in an alert by F-Secure. The article described how the new Zeus variant, "Mitmo," affected the ING bank in Poland by stealing mTANs from customers, mobile authentication numbers sent by SMS that enable online transactions. Mitmo offered mobile users ... read more
Oasis Solutions Group (www.oasisky.com), a business management software consulting firm based in Louisville, Kentucky, announced it has hired Steve Skrabak and Cindy Bryant as a Senior Support Analyst and Business Development Consultant, respectively.
Skrabak's duties will include help desk support for Sage ERP MAS 90 / 200 clients. Prior to joining Oasis Solutions, Skrabak worked as a General Manager, Director of Operational Services and Controller in a variety of industries, most recently in a franchisee company. He will be working out ... read more
BioNeutral Group, Inc. (OTC Bulletin Board: BONU), a specialty life science technology-based company, today announced that its wholly-owned subsidiary, BioNeutral Services, Inc., has been approved by the Kentucky Economic Development Finance Authority (KEDFA) to receive up to $280,000 in development incentives for up to 10 years.
At a February 24 meeting, six companies, including BioNeutral Services, Inc., were approved for economic development incentives by the KEDFA. Collectively, the six projects are expected to create 362 new jobs, nearly $12 million in ... read more
Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study (Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation) was initiated in major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events. Warfarin, the most commonly prescribed blood thinner worldwide, causes up to 100,000 serious and unnecessary adverse events every year, including thousands of deaths. Studies ... read more
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced financial results for the fourth quarter and year ended December 31, 2010.
The net loss for the fourth quarter ended December 31, 2010 was $13.9 million compared to $13.4 million during the same period in 2009. The net loss for the year ended December 31, 2010 was $54.7 million compared to $9.0 million for the year ended December 31, 2009. The increase in net loss for the 12 month period was primarily ... read more
Neuralstem, Inc. (Amex: CUR) announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single dose.
(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO )
"The initiation of clinical trial with our NSI-189 ... read more
Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study (Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation) was initiated at WellStar Health System in Marietta and other major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events. Warfarin, the most commonly prescribed blood thinner worldwide, causes up to 100,000 serious and unnecessary adverse events every ... read more
Ancor, a premier outsourcing provider of customized print and electronic
document services, has recently partnered with Online Tech, a Midwest
data center operator for IT disaster recovery facilities and services.
Ancor is the parent company for two other service organizations,
Utilitec and HealthLOGIX.
... read more
Infoblox Inc. today announced the Company’s Executive Vice President of
Product Strategy and Corporate Development, Steve Nye, will participate
in the 2011 Pacific Crest Emerging Technology Summit, which explores how
new advancements in technologies are changing businesses across
industries. Nye is scheduled to participate in a ... read more
PLEASANTON, CA -- (Marketwire) -- 03/01/11 -- IntegenX today announced that Dennis Harris, PhD, a leader in the field of biotechnology science innovation, has been appointed as Chief Scientific Officer (CSO). As CSO, Dr. Harris will lead the technology development program at IntegenX and direct the company's scientific research, collaborations, and grants and contracts strategies.
Dr. Harris is a co-founder of IntegenX and has served as a board member since 2003. Dr. Harris began his scientific career at Amersham International, ... read more
MCLEAN, VA -- (Marketwire) -- 03/01/11 -- Primus Telecommunications Group, Incorporated (PTGi) (OTCBB: PMUG), a global facilities-based integrated provider of advanced telecommunications products and services, announced today that it has completed its acquisition of Arbinet Corporation (NASDAQ: ARBX), a leading provider of wholesale telecom exchange services to carriers in an all-stock transaction. Pursuant to the definitive merger agreement dated November 10, 2010, which was further amended on December 14, 2010, it is anticipated that Arbinet stockholders will receive ... read more
JSR Corporation, along with its US operations, JSR Micro, Inc.,
announced today a new directed self-assembly (DSA) technology for the
sub-20nm half-pitch node. Developed as part of an ongoing research
agreement with IBM Research – Almaden, the new technology eliminates
dual exposure steps and is compatible ... read more
Repligen Corporation (NASDAQ: RGEN) announced today that the Company
President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will
present at the Cowen & Company 31st Annual Healthcare
Conference on Tuesday March 8th, 2011 at 8:45 a.m. EST at the Boston
Marriott Copley Place Hotel, in ... read more
(OTCBB: PKTX) (http://www.protokinetix.com),
a biotechnology company that has developed and patented a family of
synthetic anti-aging glycopeptides (AAGP™)
for medicine, biotechnology and cosmetic industries today announced that
the Company has completed the funding requirements for trials to test
... read more
KemPharm, Inc. (“KemPharm”) announced today that it has filed an Answer
and Counter-Claims against Shire LLC (“Shire”), a subsidiary of Shire
plc (LSE: SHP, NASDAQ: SHPGY). KemPharm’s Answer denies the allegations
of Shire’s Complaint, raises affirmative defenses, and makes claims for
unfair competition, antitrust violations and ... read more
Covidien (NYSE: COV), a leading global provider of healthcare products,
today announced the launch of unified packaging that leverages “One
look. One Covidien.” The new packaging unites the Company’s mission and
brand, strengthening its recognition among customers, the healthcare
community and the public.
... read more
Actuate Corporation (NASDAQ:BIRT), the people behind BIRT® and the
leading open source Business Intelligence (BI) vendor, today announced
Mobile ranks as one of the leading mobile Business Intelligence (BI)
solutions in the Dresner Advisory Services (DAS) “Mobile Business
... read more
Pervasis Therapeutics, Inc. announced today that the European Commission (EC) has granted Orphan Drug Designation for Vascugel® for the prevention of hemodialysis vascular access failure in patients with end stage renal disease (ESRD). The designation follows a positive opinion from The Committee for Orphan Medicinal Products (COMP) within the European Medicines Agency (EMA) earlier this year.
Vascugel is a novel endothelial cell-based therapy that aims to regulate the body's healing response following surgical interventions to create vascular access which are necessary ... read more